NVMI vs. TEVA

Last updated Jun 9, 2026

NVMI (Nova Ltd) and TEVA (Teva Pharmaceutical Industries Limited) are both stocks. NVMI operates in Semiconductor Equipment & Materials (Technology), while TEVA operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, NVMI returned 46.09%/yr vs -4.15%/yr for TEVA. At a 0.17 correlation, their price movements are largely independent.

Performance

NVMI vs. TEVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nova Ltd (NVMI) and Teva Pharmaceutical Industries Limited (TEVA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NVMI achieves a 54.68% return, which is significantly higher than TEVA's 6.57% return. Over the past 10 years, NVMI has outperformed TEVA with an annualized return of 46.09%, while TEVA has yielded a comparatively lower -4.15% annualized return.

NVMI

• 1D: 6.77%
• 1M: -2.53%
• YTD: 54.68%
• 6M: 52.63%
• 1Y: 134.08%
• 3Y*: 63.36%
• 5Y*: 38.40%
• 10Y*: 46.09%

TEVA

• 1D: -2.72%
• 1M: -6.91%
• YTD: 6.57%
• 6M: 17.40%
• 1Y: 87.17%
• 3Y*: 65.55%
• 5Y*: 25.39%
• 10Y*: -4.15%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NVMI vs. TEVA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NVMI Nova Ltd	54.68%	66.74%	43.35%	68.21%	-44.25%	107.51%	86.62%	66.07%	-12.08%	96.88%
TEVA Teva Pharmaceutical Industries Limited	6.57%	41.61%	111.11%	14.47%	13.86%	-16.99%	-1.53%	-36.45%	-18.63%	-46.18%

Correlation

The correlation between NVMI and TEVA is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (5Y) Calculated over the trailing 5-year period	0.27
Correlation (10Y) Calculated over the trailing 10-year period	0.24
Correlation (All Time) Calculated using the full available price history since Apr 12, 2000	0.17

The correlation between NVMI and TEVA shifts across timeframes, from 0.17 (all time) to 0.27 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap NVMI : $17.49B TEVA : $39.21B
EPS NVMI : $7.94 TEVA : $1.34
PE Ratio NVMI : 63.96 TEVA : 24.87
PEG Ratio NVMI : 2.22 TEVA : 0.19
PS Ratio NVMI : 18.68 TEVA : 2.24
PB Ratio NVMI : 12.61 TEVA : 4.76
Total Revenue (TTM) NVMI : $902.53M TEVA : $17.35B
Gross Profit (TTM) NVMI : $518.59M TEVA : $9.03B
EBITDA (TTM) NVMI : $293.89M TEVA : $3.05B

Return for Risk

NVMI vs. TEVA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVMI

NVMI Risk / Return Rank: 91
NVMI Sharpe Ratio Rank: 93
NVMI Sortino Ratio Rank: 87
NVMI Omega Ratio Rank: 86
NVMI Calmar Ratio Rank: 94
NVMI Martin Ratio Rank: 94

TEVA

TEVA Risk / Return Rank: 90
TEVA Sharpe Ratio Rank: 91
TEVA Sortino Ratio Rank: 92
TEVA Omega Ratio Rank: 91
TEVA Calmar Ratio Rank: 89
TEVA Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVMI vs. TEVA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nova Ltd (NVMI) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NVMI	TEVA	Difference
Sharpe ratio: Return per unit of total volatility	2.55	2.25	+0.30
Sortino ratio: Return per unit of downside risk	2.76	3.42	-0.66
Omega ratio: Gain probability vs. loss probability	1.36	1.43	-0.07
Calmar ratio: Return relative to maximum drawdown	6.26	4.02	+2.23
Martin ratio: Return relative to average drawdown	16.77	10.94	+5.83
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NVMI vs. TEVA - Sharpe Ratio Comparison

The current NVMI Sharpe Ratio is 2.55, which is comparable to the TEVA Sharpe Ratio of 2.25. The chart below compares the historical Sharpe Ratios of NVMI and TEVA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NVMI	TEVA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.55	2.25	+0.30
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.82	0.59	+0.22
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	1.07	-0.09	+1.16
Sharpe Ratio (All Time) Calculated using the full available price history	0.21	0.31	-0.11

Drawdowns

NVMI vs. TEVA - Drawdown Comparison

The maximum NVMI drawdown since its inception was -98.22%, which is greater than TEVA's maximum drawdown of -90.89%. Use the drawdown chart below to compare losses from any high point for NVMI and TEVA.

Drawdown Indicators

	NVMI	TEVA	Difference
Max Drawdown Largest peak-to-trough decline	-98.22%	-90.89%	-7.33%
Max Drawdown (1Y) Largest decline over 1 year	-21.56%	-21.79%	+0.23%
Max Drawdown (3Y) Largest decline over 3 years	-40.79%	-43.70%	+2.91%
Max Drawdown (5Y) Largest decline over 5 years	-52.76%	-43.70%	-9.06%
Max Drawdown (10Y) Largest decline over 10 years	-52.76%	-88.41%	+35.65%
Current Drawdown Current decline from peak	-8.66%	-50.84%	+42.18%
Average Drawdown Average peak-to-trough decline	-51.79%	-32.00%	-19.79%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.03%	8.00%	+0.03%

Volatility

NVMI vs. TEVA - Volatility Comparison

Nova Ltd (NVMI) has a higher volatility of 23.58% compared to Teva Pharmaceutical Industries Limited (TEVA) at 9.18%. This indicates that NVMI's price experiences larger fluctuations and is considered to be riskier than TEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NVMI	TEVA	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.58%	9.18%	+14.40%
Volatility (6M) Calculated over the trailing 6-month period	40.72%	23.54%	+17.18%
Volatility (1Y) Calculated over the trailing 1-year period	52.91%	38.97%	+13.94%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	47.27%	42.94%	+4.33%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	43.30%	47.34%	-4.04%

Dividends

NVMI vs. TEVA - Dividend Comparison

Neither NVMI nor TEVA has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NVMI Nova Ltd	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
TEVA Teva Pharmaceutical Industries Limited	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.88%	3.19%	1.77%

Financials

NVMI vs. TEVA - Profitability Comparison

The chart below illustrates the profitability comparison between Nova Ltd and Teva Pharmaceutical Industries Limited over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

NVMI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nova Ltd reported a gross profit of 135.69M and revenue of 235.31M. Therefore, the gross margin over that period was 57.7%.

TEVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 1.97B and revenue of 3.98B. Therefore, the gross margin over that period was 49.5%.

NVMI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nova Ltd reported an operating income of 70.84M and revenue of 235.31M, resulting in an operating margin of 30.1%.

TEVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported an operating income of 652.00M and revenue of 3.98B, resulting in an operating margin of 16.4%.

NVMI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nova Ltd reported a net income of 69.26M and revenue of 235.31M, resulting in a net margin of 29.4%.

TEVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teva Pharmaceutical Industries Limited reported a net income of 369.00M and revenue of 3.98B, resulting in a net margin of 9.3%.

Frequently Asked Questions

Can I hold both NVMI and TEVA in my portfolio?

NVMI and TEVA have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NVMI or TEVA?

NVMI has higher volatility (23.58%) compared to TEVA (9.18%). In terms of maximum drawdown, NVMI dropped -98.22% vs TEVA's -90.89%.

Which has better risk-adjusted returns?

NVMI currently has the higher Sharpe Ratio (2.55 vs 2.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.